Compumedics Limited (ASX:CMP) today announced another significant milestone of being awarded the contract to supply EEG equipment for the Neurology Department at Yale School of Medicine, Yale University, USA. Under the contract Compumedics will supply its latest EEG products comprising the new Compumedics NEUVO® Long-Term EEG Monitoring (LTEM) system, Grael®HD, Profusion EEG 4 and Curry® NS7 software. The systems are to be used for routine clinical EEG and surgical monitoring. This purchase represents another major milestone in Compumedics’ strategic entry into the global $250 million p.a. LTEM/neurology market.
The sale, with an order value of more than AUD1 million, will see the installation of Compumedics’ latest EEG products into Yale University and follows several other significant EEG orders in the USA in the first half of FY2012. The NEUVO® LTEM systems can record a minimum 64 individual channels of high-density EEG data on a single patient for days or weeks at a time. The Grael®HD system provides high definition EEG signals while the Siesta®802 remains the industry’s most compact wireless EEG recording device. Compumedics’ digital amplifier technology and breadth of EEG diagnostic offerings is state-of-the-art and provides Compumedics with a unique point of differentiation from competing offerings. Compumedics’ products provide higher quality brain recordings and more precise brain analysis than alternatives, helping to improve patient outcomes.
The Department of Neurology at Yale School of Medicine describes itself as a research, teaching, and clinical centre devoted to improving the understanding and treatment of diseases of the nervous system. The department is a major part of the Yale University School of Medicine and has several active clinical programs at local medical establishments.
Compumedics® equipment will help the Department of Neurology to achieve its goal of providing the highest level of patient care through state-of-the-art clinical programs, educating future leaders in the field of neurology and being at the forefront of neuroscience research within one of the world’s most prestigious universities. The department has a long history of being a pioneer in the field of Neurology, such as establishing one of the first epilepsy monitoring units and creating one of the first stroke centres.
Dr. David Burton, Chairman and Chief Executive Officer of Compumedics Group commented,
“This contract is another important milestone for our Company. It reinforces our commitment to our customers and the patients under their care. Compumedics has made significant investments in product development, targeting the neuro-diagnostics market to leverage its expertise in high-end amplifier design and physiological signal processing. The world-class Yale University installation will establish a new and innovative standard for long-term EEG monitoring. This project further underpins our strategy to grow our business across this important, but relatively new, market sector for Compumedics. In particular, this prestigious sale to one of the world’s pre-eminent epilepsy monitoring centres validates our key growth strategy to penetrate the global LTEM market. The LTEM market alone is more than twice the size of our existing core sleep diagnostic business.”